OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Therapeutic Opportunities of IL-22 in Non-Alcoholic Fatty Liver Disease: From Molecular Mechanisms to Clinical Applications
Wenjing Zai, Wei Chen, Hongrui Liu, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1912-1912
Open Access | Times Cited: 25
Wenjing Zai, Wei Chen, Hongrui Liu, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1912-1912
Open Access | Times Cited: 25
Showing 25 citing articles:
Bacteriophage targeting microbiota alleviates non-alcoholic fatty liver disease induced by high alcohol-producing Klebsiella pneumoniae
Lin Gan, Yanling Feng, Bing Du, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 59
Lin Gan, Yanling Feng, Bing Du, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 59
What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
Giovanni Tarantino, Vincenzo Citro
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Giovanni Tarantino, Vincenzo Citro
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Bacteroides and NAFLD: pathophysiology and therapy
Jun Zhang, Jing Zhou, Zheyun He, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 9
Jun Zhang, Jing Zhou, Zheyun He, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 9
Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates
V. A. Prikhodko, Natalia N. Bezborodkina, Sergey V. Okovityi
Biomedicines (2022) Vol. 10, Iss. 2, pp. 274-274
Open Access | Times Cited: 36
V. A. Prikhodko, Natalia N. Bezborodkina, Sergey V. Okovityi
Biomedicines (2022) Vol. 10, Iss. 2, pp. 274-274
Open Access | Times Cited: 36
B. longum CKD1 enhances the efficacy of anti-diabetic medicines through upregulation of IL- 22 response in type 2 diabetic mice
Won Jun Kim, Bum Ju Kil, Chaewon Lee, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
Won Jun Kim, Bum Ju Kil, Chaewon Lee, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
IL-22 resolves MASLD via enterocyte STAT3 restoration of diet-perturbed intestinal homeostasis
Peng Zhang, Junlai Liu, Allen Lee, et al.
Cell Metabolism (2024)
Open Access | Times Cited: 5
Peng Zhang, Junlai Liu, Allen Lee, et al.
Cell Metabolism (2024)
Open Access | Times Cited: 5
In silico-based investigation of the molecular mechanism of Artocarpus communis seed hexane fraction against metabolic syndrome
Amel Elbasyouni, Dhamodharan Prabhu, Emmanuel Oluwatofunmi Akindoyin, et al.
Journal of Molecular Modeling (2025) Vol. 31, Iss. 2
Closed Access
Amel Elbasyouni, Dhamodharan Prabhu, Emmanuel Oluwatofunmi Akindoyin, et al.
Journal of Molecular Modeling (2025) Vol. 31, Iss. 2
Closed Access
Progress and Prospects of Interleukin-22 in the Treatment of Non-alcoholic Fatty Liver Disease
Yueyin Pan, Zebo Yu
Journal of Contemporary Medical Practice (2025) Vol. 7, Iss. 1, pp. 95-99
Closed Access
Yueyin Pan, Zebo Yu
Journal of Contemporary Medical Practice (2025) Vol. 7, Iss. 1, pp. 95-99
Closed Access
Unraveling the role of the IL-20 cytokine family in neurodegenerative diseases: Mechanisms and therapeutic insights
Pouya Goleij, Afshin Amini, Mohammad Amin Khazeei Tabari, et al.
International Immunopharmacology (2025) Vol. 152, pp. 114399-114399
Closed Access
Pouya Goleij, Afshin Amini, Mohammad Amin Khazeei Tabari, et al.
International Immunopharmacology (2025) Vol. 152, pp. 114399-114399
Closed Access
AhR Activation Leads to Attenuation of Murine Autoimmune Hepatitis: Single-Cell RNA-Seq Analysis Reveals Unique Immune Cell Phenotypes and Gene Expression Changes in the Liver
Alkeiver S Cannon, Bryan Latrell Holloman, Kiesha Wilson, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
Alkeiver S Cannon, Bryan Latrell Holloman, Kiesha Wilson, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
Inflammatory liver diseases and susceptibility to sepsis
Hong Lü
Clinical Science (2024) Vol. 138, Iss. 7, pp. 435-487
Closed Access | Times Cited: 4
Hong Lü
Clinical Science (2024) Vol. 138, Iss. 7, pp. 435-487
Closed Access | Times Cited: 4
The Molecular Mechanism of Hepatic Lipid Metabolism Disorder Caused by NaAsO2 through Regulating the ERK/PPAR Signaling Pathway
Liping Wu, Shuling Zhang, Qi Zhang, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 15
Liping Wu, Shuling Zhang, Qi Zhang, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 15
Troxerutin attenuates insulin resistance via pancreatic IL-22/JAK1/STAT3 signaling activation in dihydrotestosterone-induced polycystic ovary syndrome rats
Zixuan Gao, Wang Gui, Xiaochen Ma, et al.
AJP Endocrinology and Metabolism (2022) Vol. 323, Iss. 5, pp. E405-E417
Closed Access | Times Cited: 13
Zixuan Gao, Wang Gui, Xiaochen Ma, et al.
AJP Endocrinology and Metabolism (2022) Vol. 323, Iss. 5, pp. E405-E417
Closed Access | Times Cited: 13
Novel Insights into Psychosis and Antipsychotic Interventions: From Managing Symptoms to Improving Outcomes
Adonis Sfera, Hassan Imran, Dan O. Sfera, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5904-5904
Open Access | Times Cited: 2
Adonis Sfera, Hassan Imran, Dan O. Sfera, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5904-5904
Open Access | Times Cited: 2
Washed microbiota transplantation promotes homing of group 3 innate lymphoid cells to the liver via the CXCL16/CXCR6 axis: a potential treatment for metabolic-associated fatty liver disease
Haojie Zhong, Yu-Pei Zhuang, Xinqiang Xie, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Haojie Zhong, Yu-Pei Zhuang, Xinqiang Xie, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Hepatic IL22RA1 deficiency promotes hepatic steatosis by modulating oxysterol in the liver
Yeping Huang, Fan Yu, Yue Ding, et al.
Hepatology (2024)
Closed Access | Times Cited: 2
Yeping Huang, Fan Yu, Yue Ding, et al.
Hepatology (2024)
Closed Access | Times Cited: 2
Pathogenesis from Inflammation to Cancer in NASH-Derived HCC
Simiao Yu, Jingxiao Wang, Haocheng Zheng, et al.
Journal of Hepatocellular Carcinoma (2022) Vol. Volume 9, pp. 855-867
Open Access | Times Cited: 12
Simiao Yu, Jingxiao Wang, Haocheng Zheng, et al.
Journal of Hepatocellular Carcinoma (2022) Vol. Volume 9, pp. 855-867
Open Access | Times Cited: 12
Modulation of Host-Microbe Metabolism by Cholera Toxin
Claire Chapman, Andrew Kapinos, Fabian Rivera-Chávez
Infection and Immunity (2023) Vol. 91, Iss. 5
Open Access | Times Cited: 6
Claire Chapman, Andrew Kapinos, Fabian Rivera-Chávez
Infection and Immunity (2023) Vol. 91, Iss. 5
Open Access | Times Cited: 6
Supplementation with the Probiotic Strains Bifidobacterium longum and Lactiplantibacillus rhamnosus Alleviates Glucose Intolerance by Restoring the IL-22 Response and Pancreatic Beta Cell Dysfunction in Type 2 Diabetic Mice
Won Jun Kim, Ri Ryu, Eun‐Hee Doo, et al.
Probiotics and Antimicrobial Proteins (2023)
Closed Access | Times Cited: 4
Won Jun Kim, Ri Ryu, Eun‐Hee Doo, et al.
Probiotics and Antimicrobial Proteins (2023)
Closed Access | Times Cited: 4
Gut microbiota-mediated IL-22 alleviates metabolic inflammation
Kaijun Wang, Miao Zhou, Hongbin Si, et al.
Life Sciences (2023) Vol. 334, pp. 122229-122229
Closed Access | Times Cited: 4
Kaijun Wang, Miao Zhou, Hongbin Si, et al.
Life Sciences (2023) Vol. 334, pp. 122229-122229
Closed Access | Times Cited: 4
Oxidative Stress and Annexin A2 Differential Expression in Free Fatty Acids-Induced Non-Alcoholic Fatty Liver Disease in HepG2 Cells
Vinícius Marques Arruda, G. Azevedo, Maria Júlia Maia Gonçalves Granato, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9591-9591
Open Access | Times Cited: 1
Vinícius Marques Arruda, G. Azevedo, Maria Júlia Maia Gonçalves Granato, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9591-9591
Open Access | Times Cited: 1
Lipid-encapsulated mRNA encoding an extended serum half-life interleukin-22 ameliorates metabolic disease in mice
Susanna Canali, Alexander W. Fischer, Mychael Nguyen, et al.
Molecular Metabolism (2024) Vol. 86, pp. 101965-101965
Open Access
Susanna Canali, Alexander W. Fischer, Mychael Nguyen, et al.
Molecular Metabolism (2024) Vol. 86, pp. 101965-101965
Open Access
Review of the potential value of serum interleukin levels as prognostic biomarkers of liver failure
Yong Lin, Geng-Jie Yan, Meiyan Liu, et al.
World Journal of Clinical Cases (2024) Vol. 12, Iss. 27, pp. 6045-6056
Open Access
Yong Lin, Geng-Jie Yan, Meiyan Liu, et al.
World Journal of Clinical Cases (2024) Vol. 12, Iss. 27, pp. 6045-6056
Open Access
Modulating intestinal neuroimmune VIPergic signaling attenuates the reduction in ILC3-derived IL-22 and hepatic steatosis in MASLD
Henry H. Nguyen, Jhimmy Talbot, Dayi Li, et al.
Hepatology Communications (2024) Vol. 8, Iss. 11
Open Access
Henry H. Nguyen, Jhimmy Talbot, Dayi Li, et al.
Hepatology Communications (2024) Vol. 8, Iss. 11
Open Access
Hepatic macrophage mediated immune response in liver steatosis driven carcinogenesis
Taojian Tu, Mario Alba, Aditi A. Datta, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 2
Taojian Tu, Mario Alba, Aditi A. Datta, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 2
